Literature DB >> 9642257

Gbeta binding to GIRK4 subunit is critical for G protein-gated K+ channel activation.

G Krapivinsky1, M E Kennedy, J Nemec, I Medina, L Krapivinsky, D E Clapham.   

Abstract

The cardiac G protein-gated K+ channel, IKACh, is directly activated by G protein beta gamma subunits (Gbeta gamma). IKAChis composed of two inward rectifier K+ channel subunits, GIRK1 and GIRK4. Gbeta gamma binds to both GIRK1 and GIRK4 subunits of the heteromultimeric IKACh. Here we delineate the Gbeta gamma binding regions of IKACh by studying direct Gbeta gamma interaction with native purified IKACh, competition of this interaction with peptides derived from GIRK1 or GIRK4 amino acid sequences, mutational analysis of regions implicated in Gbeta gamma binding, and functional expression of mutated subunits in mammalian cells. Only two GIRK4 peptides, containing amino acids 209-225 or 226-245, effectively competed for Gbeta gamma binding. A single point mutation introduced into GIRK4 at position 216 (C216T) dramatically reduced the potency of the peptide in inhibiting Gbeta gamma binding and Gbeta gamma activation of expressed GIRK1/GIRK4(C216T) channels. Conversion of 5 amino acids in GIRK4 (226-245) to the corresponding amino acids found in the G protein-insensitive IRK1 channel, completely abolished peptide inhibition of Gbeta gamma binding to IKACh and Gbeta gamma activation of GIRK1/mutant GIRK4 channels. We conclude from this data that Gbeta gamma binding to GIRK4 is critical for IKACh activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642257     DOI: 10.1074/jbc.273.27.16946

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma.

Authors:  C Cantí; K M Page; G J Stephens; A C Dolphin
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel.

Authors:  J L Leaney; A Tinker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors.

Authors:  J K Scott; S F Huang; B P Gangadhar; G M Samoriski; P Clapp; R A Gross; R Taussig; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

4.  Discovery of ligands for beta gamma subunits from phage-displayed peptide libraries.

Authors:  Alan V Smrcka; Jamie K Scott
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

5.  Modulation of rat atrial G protein-coupled K+ channel function by phospholipids.

Authors:  D Kim; H Bang
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

6.  Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site.

Authors:  S L Rogalski; C Chavkin
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

7.  Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels.

Authors:  W Zhou; C Arrabit; S Choe; P A Slesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

8.  Graded contribution of the Gbeta gamma binding domains to GIRK channel activation.

Authors:  Rona Sadja; Noga Alagem; Eitan Reuveny
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

Review 9.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

10.  Blockade of ethanol-induced potentiation of glycine receptors by a peptide that interferes with Gbetagamma binding.

Authors:  Leonardo Guzman; Gustavo Moraga-Cid; Ariel Avila; Maximiliano Figueroa; Gonzalo E Yevenes; Jorge Fuentealba; Luis G Aguayo
Journal:  J Pharmacol Exp Ther       Date:  2009-09-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.